Mélodie Duval

Mélodie Duval is a Senior Scientist at T3 Pharmaceuticals AG, specializing in R&D for next-generation cancer treatments utilizing live bacteria, focusing on identifying new clinical candidates and improving strains while also contributing to areas such as patents, CMC, and QC. Previously, Mélodie served as a Post-doctoral researcher at Institut Pasteur under Pascale Cossart, investigating antibiotic resistance mechanisms in Listeria monocytogenes, and as a PhD student at CNRS, concentrating on the molecular genetics of Escherichia coli ribosomes and stress responses. Mélodie has experience in teaching biochemistry at Université de Strasbourg and has a strong educational background with a PhD in Molecular Biology and a diploma in innovation management and technology transfer.